Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial. (2023)

First Author: Heath PT
Attributed to:  MRC Centre for Virus Research (MRC CVR) - COVID-19 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciac803

PubMed Identifier: 36210481

Publication URI: http://europepmc.org/abstract/MED/36210481

Type: Journal Article/Review

Volume: 76

Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Issue: 3

ISSN: 1058-4838